Ads
related to: site guided mutation therapy for prostate cancer- Side Effects & Safety
Learn About Possible Side Effects
You May Experience During Treatment
- Video Library
Watch Helpful Patient Videos.
Visit The Video Library.
- Patient FAQ
Visit The Patient Website To
Find Answers To Common Questions.
- Download Useful Materials
Find The Patient Guide & Other
Helpful Resources Here.
- FDA-Approved Treatment
Visit The Patient Website To
Learn More About This Treatment.
- Patient Assistance Info
Discover Patient Support Downloads
And Materials For Treatment.
- Side Effects & Safety
Search results
Results From The WOW.Com Content Network
Radiation therapy is commonly used in prostate cancer treatment. It may be used instead of surgery or after surgery in early-stage prostate cancer (adjuvant radiotherapy). Radiation treatments also can be combined with hormonal therapy for intermediate risk disease, when surgery or radiation therapy alone is less likely to cure the cancer.
Site-directed mutagenesis is used to generate mutations that may produce a rationally designed protein that has improved or special properties (i.e.protein engineering). Investigative tools – specific mutations in DNA allow the function and properties of a DNA sequence or a protein to be investigated in a rational approach. Furthermore ...
TMPRSS2-ERG fusion gene is the most frequent, present in 40% - 80% of prostate cancers in humans. ERG overexpression contributes to development of androgen-independence in prostate cancer through disruption of androgen receptor signaling. [17]
Patient derived xenografts (PDX) are models of cancer where the tissue or cells from a patient's tumor are implanted into an immunodeficient or humanized mouse. [1] It is a form of xenotransplantation. PDX models are used to create an environment that allows for the continued growth of cancer after its removal from a patient.
Mutations of this gene are a step in the development of many cancers, specifically glioblastoma, lung cancer, breast cancer, and prostate cancer. Genes corresponding to PTEN ( orthologs ) [ 7 ] have been identified in most mammals for which complete genome data are available.
The 16 possible mutation types of the substitution class C>A are shown as an example. Once the mutation catalog (e.g. counts for each of the 96 mutation types) of a tumor is obtained, there are two approaches to decipher the contributions of different mutational signatures to tumor genomic landscape:
Ads
related to: site guided mutation therapy for prostate cancer